Navigation Links
ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
Date:11/12/2008

ocolitis caused by Staphylococcus aureus, including methicillin-resistant strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, http://www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Forward-Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide the Company's current expectations or forecasts of future events. Forward-looking statements in this press release include statements regarding ViroPharma's clinical development programs. Our actual results could differ materially from those results expressed in, or implied by, these forward-looking statements. The development and commercialization of pharmaceutical products is subject to risks and uncertainties. The data that were presented at the ACAAI Annual Meeting regarding the in the ongoing open-label study of Cinryze for acute treatment of HAE is partial data from an ongoing open label study. There can be no assurance that the complete data from this study will demonstrate that Cinryze successfully treats all types of acute hereditary angioedema (HAE) attacks and may not be predictive
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
2. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
3. ViroPharma Announces Discontinuation of HCV-796 Development
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. ViroPharma to Present at the Natixis Bleichroeder Conference
7. ViroPharma to Present at Three Upcoming Healthcare Conferences
8. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
9. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
10. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
11. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 Mike Rowe , ... at Good Neighbor Pharmacy,s 2015 ThoughtSpot ... 1 in Las Vegas, Nev. ... "Somebody,s Gotta Do It," and Discovery Channel,s, "Dirty Jobs," Mr. ... the nation,s  "unsung heroes" – people whose hard work, sacrifice ...
(Date:7/28/2015)... , July 28, 2015 Baebies, Inc. today ... totaling $13 million. The oversubscribed round of financing included ... the Duke endowment), Cunning Capital, Triad, LLC, the Duke ... Biotechnology Center. Many of Advanced Liquid Logic,s (ALL) former ... also invested. "Rex is pleased to ...
(Date:7/28/2015)... 28, 2015  Zipnosis, the first virtual care solution to ... launch their own branded virtual care service line, announced an ... CareNow is currently in use. ... As health ... recognize the value of providing their own branded online care ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3
(Date:7/29/2015)... ... July 29, 2015 , ... We are privileged to announce that U.S. News & ... the ninth best ophthalmology hospital in the nation for 2015-2016. This marks the 21st consecutive ... ophthalmology. , “It is an honor to be included in the top 10 ophthalmology ...
(Date:7/29/2015)... Buckner, KY (PRWEB) , ... July 29, 2015 ... ... upcoming episode of American Farmer, airing fall of 2015 on RFD-TV. , Fastline ... segment, viewers will learn about Fastline.com, which contains the largest and freshest searchable ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... Hackett Hemwall Foundation in March, Steven W. Meier M.D., a prominent orthopedic surgeon ... to qualifying patients with demonstrated financial need. , “We are thrilled for this ...
(Date:7/29/2015)... ... July 29, 2015 , ... It is unique for a health center to ... of care. One that is very hands on and resident oriented, and one to ... “She’s bringing great passion and energy, as well as a strong commitment to helping ...
(Date:7/29/2015)... ... 29, 2015 , ... Stealth Therapeutics Inc. announced today that ... the Invisiport at Wheaton Franciscan Healthcare in Milwaukee, Wis. The Invisiport product line, ... patient-friendly alternative to traditional chest ports and peripherally inserted central catheters (PICCs). It ...
Breaking Medicine News(10 mins):Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3
... Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics ... covers the use of endonuclease-based reporting in PCR and other ... filed a claim in opposition to this patent which was ... Munich on May 28. , , The ...
... ... Leading Healthcare Cost-Management Company , ... Westminster, Colo. (PRWEB) June 16, 2009 -- Silver Creek ... integration and governance announced today that their DataLens™ System was selected by Broadlane®, ...
... SAN FRANCISCO, California, June 16, Autonomy Corporation plc (LSE: ... the enterprise, today announced,that the Greater Cincinnati Behavioral Health ... capture, route, store and manage,its patients records. With Autonomy, ... all of their patients, records online, rather than having ...
... ... better decisions , ... Indianapolis, Indiana (Vocus) June 16, 2009 -- United Benefit Advisors, LLC (UBA), one of ... 2009 UBA Employer Benefit Perspectives survey (video) , which delineates employers, positions ...
... Mike Ramsey, a ... explains the process in his book "Stop Sweating and Start Living." , ... (PRWEB) June 16, 2009 -- If you suffer ... save you money and frustration., , , , ,Written by Mike Ramsey, who first started ...
... ... Manhattan LASIK Center, even though the iLASIK™ Procedure is not without risk, wearing contacts has ... of magnitude more common when compared to the iLASIK procedure. , ... New York, NY (PRWEB) June 16, 2009 -- Board ...
Cached Medicine News:Health News:Enigma Diagnostics Announces Patent On Real-Time Monitoring of Amplification Reactions Upheld In Entirety Following Opposition From BD at European Patent Office 2Health News:Broadlane Selects Silver Creek Systems To Accelerate Core Business Analysis And New Client Services 2Health News:Broadlane Selects Silver Creek Systems To Accelerate Core Business Analysis And New Client Services 3Health News:Greater Cincinnati Behavioral Health Services Standardizes on Autonomy's Meaning-Based Technologies 2Health News:Greater Cincinnati Behavioral Health Services Standardizes on Autonomy's Meaning-Based Technologies 3Health News:Employees Increasingly Accept and Understand Reductions in Health Plan Benefits and Premium-Cost Sharing 2Health News:Employees Increasingly Accept and Understand Reductions in Health Plan Benefits and Premium-Cost Sharing 3Health News:Man Discovers Cure for Excessive Sweating 2Health News:Kevin Niksarli, M.D. of Manhattan Lasik Center Reviews Pros and Cons of Contact Lenses vs. iLASIK at an International Meeting on 7/1/2009 2
Indications For Usage: ,Pediatric (recommended tidal volume 70-250ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intend...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
Medicine Products: